Abstract
MSCs are adherent bone marrow stromal cells that can selfrenew and differentiate into osteogenic, chondrogenic, adipogenic and myogenic lineages
. Several signalling pathways have been implicated in regulating stem cell self-renewal and lineage commitment [23] [24] [25] [26] [27] . Osteogenic differentiation is under the control of hormonal and local factors converging onto a finite number of transcriptional regulators that ultimately determine the fate of cells committing to the osteogenic lineage [7, 28] . BMPs play an important role in stem cell biology [29, 30] , as well as in regulating cell proliferation and differentiation during development [1, 3, 4] . Genetic disruptions of BMPs have resulted in skeletal and extraskeletal abnormalities [1, 31] . Although not well understood, BMPs are involved in regulating osteoblast differentiation and bone formation [5, 7, 32, 33] .
Wnt/␤-catenin signalling also plays an important role in skeletal development and osteoblast differentiation [7, 24, 28, [34] [35] [36] [37] [38] . Wnts are a family of secreted proteins that regulate many embryonic processes [7, 35, 39] . They bind to their cognate receptor frizzled (Fz) [27, [40] [41] [42] [43] . Mutations in LRP-5 affect skeletal development and bone mass acquisition [44] [45] [46] . Studies from genetically manipulated animal models suggest that high levels of canonical Wnt/␤-catenin with the presence of Runx2 may promote osteoblastogenesis at the expense of chondrocyte differentiation [35, 38] . A recent report has demonstrated that ␤-catenin signalling plays a disparate role in different phases of fracture repair [47] , suggesting that Wnt/ ␤-catenin may play a similar but distinct role in skeletogenesis versus bone regeneration. Conflicting results have indicated that canonical Wnt/␤-catenin may inhibit osteogenic differentiation [48] [49] [50] [51] [52] , and non-canonical Wnts were also shown to promote osteogenic differentiation [53, 54] . Thus 
and LRP-5/6 co-receptors, and activate distinct signalling pathways, including the canonical ␤-catenin pathway. Wnt antagonists FrzB and Dkk1 inhibit the binding of Wnt ligands to their receptors. In the absence of Wnt signalling, ␤-catenin is degraded by the proteasome system after GSK-3␤ dependent phosphorylation. In the presence of Wnt signalling, unphosphorylated ␤-catenin accumulates in the cytoplasm and translocates into the nucleus where it associates with Tcf/LEF transcription factors to regulate the expression of target genes

Preparation of mouse embryonic fibroblasts (MEFs)
MEFs were isolated from post-coitus day 13.5 mice, as previously described [55] . Each embryo was dissected into 10 ml sterile phosphate buffered saline (PBS), voided of its internal organs, and sheared through an 18- 
Selection and construction of RNAi silencing vectors
We used our recently developed pSOS system to select and validate efficacious short interfering double-stranded RNA (siRNA) target sites of mouse ␤-catenin [56] , and designed three pairs of oligonucleotides containing siRNA target sites for the coding region of mouse ␤-catenin using Dharmacon's siDESIGN program (Supporting Table S1 ). The oligo pairs were annealed and subcloned into the Sfi I site of pSES, resulting in adenoviral shuttle vectors pSES-simBCs. The shuttle vectors were used to generate recombinant adenoviral plasmids, which were pooled to produce adenovirus AdR-simBC using the AdEasy system [41, 43, [56] [57] [58] . The resultant adenoviral vector also expresses monomeric RFP. Knockdown efficiency was assessed by qPCR and functional assays of ␤-catenin signalling.
Construction of recombinant adenoviruses expressing Wnt3A, BMP-9, ␤-catenin*, DKK1, FrzB, Runx2, sLRP-5 and sLRP-6
Adenoviruses expressing Wnt3A, BMP-9, ␤-catenin*, DKK1, Runx2 and FrzB were generated previously using the AdEasy system [15-17, 41, 43, 57, 58] [16, 17, 41, 43, 57, 58] .
Preparation of conditioned medium
BMP-9 and Wnt3A conditioned media were prepared as described [59] [12, 13, [15] [16] [17] . 
Mineralization assay
RNA isolation and quantitative real-time PCR (qPCR) analysis
Total RNA was isolated using TRIZOL Reagents (Invitrogen). qPCR was carried out as described [15] [16] [17] 
Immunofluorescence staining
Immunofluorescence staining was carried out as described [15] [16] [17] 
ChIP assay
ChIP was carried out as described previously [17] . 
Histological evaluation
Retrieved tissues were decalcified, fixed in 10% formalin, and embedded in paraffin. Serial sections of the embedded specimens were stained with haematoxylin and eosin. Masson's Trichrome stain was carried out as described [13] .
MicroCT analysis
The 
Results
Canonical Wnt3A acts synergistically on BMP-9-induced osteogenic differentiation of MSCs
Although the exact mechanisms remain to be fully delineated, both Wnt and BMP signalling pathways are shown to regulate the proliferation and differentiation processes of MSCs [7] . As shown in Fig. 1A source of MSCs [55] . As illustrated in Fig. 2D, overexpression Fig. 2C , FrzB was a more potent inhibitor than DKK1 (Fig. 2D) , which was also confirmed by the histochemical staining assay of ALP activity (Fig. 2E) . Overexpression of sLRP-5 or sLRP-6 did not inhibit BMP-9-induced ALP activity (Supporting Fig. S1A) [27, 34, 40, 62, 64] . We examined whether overexpression of the stabilized ␤-catenin exerted any effects on BMP-9-induced osteogenic differentiation. We previously constructed a recombinant adenoviral vector that expresses a stabilized form (S33Y) of human ␤-catenin [17, 61, 65] . Overexpression of the stabilized ␤-catenin alone in C3H10T1/2 resulted in a weak but detectable increase in ALP activity (Fig. 3A,  top row) . However, BMP-9-induced ALP activity was drastically enhanced by the overexpression of the stabilized ␤-catenin (Fig. 3A, bottom row) . A quantitative analysis of BMP-9-induced ALP activity further confirmed that ␤-catenin can potentiate BMP-9-induced osteogenic differentiation of MSCs in a dosedependent manner (Fig. 3B) .
FrzB (and DKK1, to a lesser extent) inhibits BMP-9-induced osteogenic differentiation of MSCs and MEFs
Fig. 2 Wnt antagonists inhibit BMP-9-induced osteogenic differentiation of MSCs and mouse embryonic fibroblasts (MEFs). (A) Effective transduction of C3H10T1/2 cells by adenoviral vectors expressing the
Knockdown of ␤-catenin expression inhibits BMP-9-induced ALP activity in MSCs
We next sought to determine the importance of ␤-catenin in BMP-9-induced osteogenic differentiation by silencing ␤-catenin expression in MSCs. Using our recently developed pSOS system [56] , we selected and validated three siRNA sites targeting the coding region of mouse ␤-catenin (Fig. 4A ). An adenovirus pool that expresses all three siRNA sites was then generated. The resultant AdR-simBC, which also expresses RFP marker, was shown to effectively transduce C3H10T1/2 progenitor cells (Fig. 4A) . AdR-simBC was shown to inhibit Wnt3A conditioned medium-induced nuclear accumulation of ␤-catenin protein (Fig. 4A) , as well as to inhibit Wnt3A-induced ␤-catenin/Tcf4 transcriptional activation in a dose-dependent manner (Fig. 4B) . These results demonstrated that silencing ␤-catenin expression was achieved by adenovirus-mediated expression of ␤-catenin siRNAs.
We subsequently examined the effect of ␤-catenin knockdown on osteogenic differentiation induced by Wnt3A or BMP-9. As shown in Fig. 4C (Fig. 4D,  and Supporting Fig. S1B) . A similar inhibitory effect of ␤-catenin knockdown on BMP-9-induced ALP activity was observed in MEF cells (Fig. 4E) . These results strongly suggest that ␤-catenin may play an important role in regulating BMP-9-induced early stage of osteogenic differentiation of MSCs.
Fig. 3 Overexpression of a stabilized ␤-catenin enhances BMP-9-induced alkaline phosphatase (ALP) activity in MSCs. (A) Qualitative assessment of ␤-catenin-mediated augmentation of BMP-9-induced ALP activity. C3H10T1/2 cells were infected with varying titres of Ad␤-Cat* and/or AdBMP-9. ALP activities were histochemically stained at 10 days after infection. (B) Quantitative assessment of ␤-catenin-mediated enhancement of BMP-9-induced ALP activity. C3H10T1/2 cells were co-infected with a fixed titre of AdBMP-9 and varying titres of Ad␤-Cat*. ALP activities were quantitatively assessed at the indicated time-points. Data are present as mean Ϯ S.D.
Fig. 4 Knockdown of ␤-catenin inhibits BMP-9-induced early osteogenic marker alkaline phosphatase (ALP) activity in MSCs and mouse embryonic fibroblasts (MEFs). (A) Construction and verification of siRNAs targeting mouse ␤-catenin expression, simBC. The three listed candidate siRNA sites were validated using our recently developed pSOS system and subcloned into an adenoviral shuttle vector. The resultant adenovirus AdR-simBC, which also expresses RFP, was used to infect C3H10T1/2 cells. The infection efficiency was assessed under a fluorescence microscope. With immunofluorescence stain using an anti-␤-catenin antibody, AdR-simBC effectively knocked down Wnt3A-induced ␤-catenin accumulation in C3H10T1/2 cells. BF, bright field. (B) AdR-simBC effectively inhibits Tcf4/LEF1 reporter activity. C3H10T1/2 cells were transfected with TOP-Luc reporter and infected with varying titres of AdR-simBC, in the presence or absence of Wnt3A conditioned medium. At 36 hrs, cells were collected for luciferase assay. (C) Silencing of ␤-catenin inhibits Wnt3A-induced ALP activity in MSCs. C3H10T1/2 cells were infected with varying titres of AdR-simBC, in the presence or absence of Wnt3A conditioned medium. ALP activities were quantitatively assessed at the indicated time-points. (D) Silencing of ␤-catenin inhibits BMP-9-induced ALP activity in MSCs. C3H10T1/2 cells were infected with varying titres of AdR-simBC, in the presence or absence of BMP-9 conditioned medium. ALP activities were quantitatively assessed at the indicated time-points. (E) Silencing of ␤-catenin inhibits BMP-9-induced ALP activity in MEFs. Primary MEFs were infected with varying titres of AdR-simBC, in the presence or absence of BMP-9 conditioned medium. ALP activities were quantitatively assessed at the indicated time-points. All data are present as mean Ϯ S.D.
Fig. 5 ␤-Catenin also plays an important role in BMP-9-induced late stage of osteogenic differentiation. (A) Synergistic effect between ␤-catenin and BMP-9 on osteocalcin promoter reporter. C3H10T1/2 cells were transfected with p6OSE2-Luc reporter and infected with varying titres of Ad␤-Cat*, in the presence or absence of BMP-9 conditioned medium. At 48 hrs, cells were collected for luciferase assay. Data are present as mean Ϯ S.D. (B) Synergistic effect between ␤-catenin and Runx2 on osteocalcin promoter reporter. C3H10T1/2 cells were transfected with p6OSE2-Luc reporter and co-infected with varying titres of Ad␤-Cat* and/or AdRunx2. At 48 hrs, cells were collected for luciferase assay. Data are present as mean Ϯ S.D. (C) Knockdown of ␤-catenin inhibits BMP-9-induced activation of osteocalcin promoter reporter. C3H10T1/2 cells were transfected with p6OSE2-Luc and infected with varying titres of AdRsimBC in the presence of BMP-9 conditioned medium. Cells were collected for luciferase at the indicated time-points. (D) Knockdown of ␤-catenin inhibits BMP-9-induced expression of late osteogenic markers. C3H10T1/2 cells were co-infected with AdBMP-9 and AdR-simBC or AdGFP for 10 days. Total RNA was isolated for RT-PCR and qPCR analysis using primers specific for mouse osteocalcin and osteopontin. Experiments were done in triplicate. (E) Silencing of ␤-catenin and FrzB overexpression inhibit BMP-9-induced mineralization. C3H10T1/2 cells were co-infected with AdBMP-9 and AdFrzB, AdR-simBC, or AdGFP. At 14 and 21 days after infection, cells were fixed and subjected to Alizarin Red S staining. Representative images are shown (magnification, 40ϫ).
␤-Catenin plays an important role in the BMP-9-induced late stage differentiation of MSCs
Although ALP is a well-established early osteogenic marker, it is hardly an accurate predictor of the late stage of osteogenic differentiation and bone formation [6, 7, 12, 13] . Thus, we sought to determine whether ␤-catenin played any role in the BMP-9-induced late stage of osteogenic differentiation. Osteocalcin and osteopontin are well-characterized markers of late osteogenesis [6, 7, 12, 13] . Using a commonly used Runx2-regulated osteocalcin promoter reporter [63] , we found that overexpression of the stabilized ␤-catenin enhanced BMP-9-induced reporter activity (Fig. 5A) . Osteocalcin is a known target of the osteogenic regulator Runx2 [66, 67] , and overexpression of the stabilized ␤-catenin acted synergistically on Runx2-induced osteocalcin reporter activity (Fig. 5B) . Conversely, silencing ␤-catenin expression resulted in a drastic decrease in BMP-9-stimulated osteocalcin promoter activity (Fig. 5C) . Quantitative PCR further confirmed that knockdown of the ␤-catenin expression inhibited BMP-9-induced expression of the late osteogenic markers osteocalcin and osteopontin in C3H10T1/2 cells (Fig. 5D) . Accordingly, either overexpression of FrzB or knockdown of ␤-catenin expression was shown to effectively inhibit BMP-9-induced expression of osteocalcin and osteopontin in MEF cells (Supporting Fig. S2A) . Furthermore, we found that either overexpression of FrzB or knockdown of ␤-catenin expression effectively inhibited the BMP-9-induced in vitro mineralization in C3H10T1/2 cells (Fig. 5E ) and in MEF cells (Supporting Fig. S2B ). These findings suggest that canonical Wnt/␤-catenin signalling may play an important role in regulating both early and late stages of BMP-9-induced osteogenic differentiation. (Fig. 6A, top row) . The infected cells were collected and injected subcutaneously into athymic mice. At 5 weeks after injection, animals were killed, and the injection sites were retrieved. The gross appearance of the retrieved samples indicated that silencing ␤-catenin expression inhibited the formation of ectopic bony masses in a dose-dependent fashion (Fig. 6A,  bottom row) . A similar, if not more marked, inhibitory effect on bone formation was also observed in the implantation experiments using the MEF cells transduced with AdBMP-9 and AdRsimBC (Fig. 6B) . When the ectopic bone formation was quantitatively analysed using microCT (Fig. 6C) , silencing ␤-catenin expression (at the high dose of AdR-simBC) inhibited bone formation by 80% in C3H10T1/2 cells and 94% in MEFs, respectively (Fig. 6D) Fig. 2C and D) .
Silencing of ␤-catenin expression inhibits BMP-9-induced ectopic bone formation in vivo
The above in vitro data demonstrated that canonical Wnt/␤-catenin signalling plays an important role in BMP-9-induced osteogenic differentiation of MSCs. We sought to confirm these findings in vivo via stem cell implantation experiments. To knockdown ␤-catenin expression in MSCs, we co-infected C3H10T1/2 cells with AdBMP-9 and different titres of AdR-simBC (or AdRFP as controls) for 15 hrs
. Further, consistent with our in vitro results, FrzB effectively inhibited BMP-9-induced ectopic bone formation in the MEF cells (Supporting
Histological evaluation indicated that silencing ␤-catenin expression inhibited BMP-9-induced osteogenic differentiation and osteoblast maturation in MSCs. Specifically, silencing ␤-catenin expression led to a marked decrease in osteoblast activity and bone formation upon BMP-9 stimulation (Fig. 6E, parts b and  d versus a and c) . Trichrome stain indicated that, while the BMP-9 control samples exhibit abundantly fully ossified matrix, samples retrieved from AdR-simBC co-infected MSCs display only focal ossification and a significant amount of osteoid or cartilaginous collagen matrix (Fig. 6E, parts f and h versus e and g ). The presence of cartilage matrix in the samples co-transduced with BMP-9 and simBC was further confirmed by Alcian Blue stain (Fig. 6E, parts j and l versus i and k) . Histological analysis also indicated that FrzB overexpression inhibited BMP-9-mediated osteogenic differentiation and ossification (Supporting Fig. 3) . These results further confirm that canonical Wnt/␤-catenin signalling plays an important role in BMP-9-induced osteogenesis.
BMP-9 induces the recruitment of both Runx2 and ␤-catenin to osteocalcin promoter.
It has been reported that there is crosstalk between Wnt and TGF-␤/BMP signalling pathways [7, [68] [69] [70] . We have demonstrated that ␤-catenin acts synergistically with BMP-9 or Runx2 on regulating osteocalcin promoter (Fig. 5A and B) . It has been reported that Runx2 may physically interact with ␤-catenin and Tcf/Lef1 complex [71, 72] . We asked whether BMP-9 induced the recruitment of Runx2 and ␤-catenin to the osteocalcin promoter. As illustrated in Fig. 7A (Fig. 7B) . The presence of osteocalcin promoter fragments in the immunoprecipitated complexes was determined by semi-quantitative PCR analysis using two pairs of primers (Fig. 7A) . As expected, BMP-9 stimulation induced the Runx2 binding to osteocalcin promoter (Fig. 7C, first lane) , while the basal Runx2 binding to osteocalcin promoter was undetectable (Fig. 7C, third lane) . Interestingly, expression of the stabilized ␤-catenin also induced the Runx2 binding to osteocalcin promoter (Fig. 7C, second lane) , suggesting that ␤-catenin may facilitate the recruitment of Runx2 to osteocalcin promoter. Reciprocal immunoprecipitation using an anti-␤-catenin antibody further demonstrated that BMP-9 stimulation induced the recruitment of ␤-catenin/Tcf complex to osteocalcin promoter (Fig. 7D) . These results were reproducible in at least three independent experiments, and the initial input for each ChIP assay was comparable (Fig. 7E) [73] . The ␤-catenin signalling is critical for BMP2 to induce ectopic bone formation [47, 74] [69, [76] [77] [78] [79] . It was also shown that Runx2 formed a complex with Lef1/Tcf4 and regulated downstream target genes [71, 72] . However, the signalling crosstalk may be more complicated, as Lef-1 was found to repress the osteocalcin promoter via interaction with Cbfa1/Runx2 [48, 52] ; and it has recently been reported that canonical Wnt signalling promotes osteogenesis by directly stimulating Runx2 expression [80] . Thus, molecular mechanism underlying the crosstalk between BMP-9 and canonical Wnt/␤-catenin needs to be further investigated.
The mechanism underlying the distinct roles of Wnt inhibitors in BMP-9 signalling remains to be defined. Disruption by Dkk1 allows for unphosphorlyated ␤-catenin to stimulate osteogenesis [46] , and bone mass is inversely proportional to Dkk1 levels in mice [81] . A recent study has also demonstrated that Dkk2 may play a role in late stages of osteoblast differentiation into mineralized matrix [82] . It has been shown that Wnt/␤-catenin signalling in osteoblasts may coordinate postnatal bone acquisition by controlling the differentiation of both osteoblasts and osteoclasts [83] , and by regulating osteoblast and chondrocyte differentiation during skeletogenesis [84] [85] [86] 
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